Duchenne Muscular Dystrophy (DMD) Therapeutics Market by Type (Small Molecules and Biologics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Global demand for Duchenne Muscular Dystrophy (DMD) Therapeutics was valued at approximately USD 2.36 Billion in 2018, and is expected to generate revenue of around USD 20.56 Billion by end of 2025, growing at a CAGR of around 36.3% between 2019 and 2025.

13-Feb-2020 | Number of pages: 110 | Report Code: ZMR-5242 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the Duchenne Muscular Dystrophy (DMD) therapeutics market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Duchenne Muscular Dystrophy (DMD) therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Duchenne Muscular Dystrophy (DMD) therapeutics market on a global as well as regional level.

According to the report, global demand for Duchenne Muscular Dystrophy (DMD) therapeutics market was valued at approximately USD 2.36 Billion in 2018, and is expected to generate revenue of around USD 20.56 Billion by end of 2025, growing at a CAGR of around 36.3% between 2019 and 2025.

In order to give the users of this report a comprehensive view on the Duchenne Muscular Dystrophy (DMD) therapeutics market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein type segment is benchmarked based on their market size, growth rate and general attractiveness.

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market

The report provides company market share analysis in order to give a broader overview of the key players in the Duchenne Muscular Dystrophy (DMD) therapeutics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the Duchenne Muscular Dystrophy (DMD) therapeutics market on global and regional basis.

Duchenne muscular dystrophy is a harsh kind of muscular dystrophy. The indication of muscle weakness typically begins at the age of four in boys and deteriorates rapidly. Most of the affected people are incapable of walking by the age of 12. The affected muscles tend to look bigger because of augmented fat content. Constant research efforts in comprehending the etiology of Duchenne muscular dystrophy gave way to the recognition of the dystrophin gene that is accountable for coding patients.

Factors such as growing funding for research and development activities and technological advancements in diagnostic techniques will act as major driving factors in the growth of global Duchenne Muscular Dystrophy (DMD) therapeutics market. Efforts taken by governments and non-government organizations to create awareness will act as an opportunity for the market players in the Duchenne Muscular Dystrophy (DMD) therapeutics market. Nonetheless, lack of awareness and dearth of skilled researchers will restrict the growth of global Duchenne Muscular Dystrophy (DMD) therapeutics market.

The global Duchenne Muscular Dystrophy (DMD) therapeutics market has been split into type and region. Based on type, Duchenne Muscular Dystrophy (DMD) therapeutics market has been segmented into small molecules and biologics. The biologics segment accounted for the highest market share in 2018 due to ongoing research on biologics and anticipated launch of biologics currently in late phases of clinical trials.

North America will be the leading region during the forecast period. High investment in research and development of Duchenne Muscular Dystrophy (DMD) therapeutics and presence of major manufacturers will boost the market growth in this region. Europe is expected to be the second major market. The key reasons are efforts taken by health agencies and advantageous reimbursement scenario. Asia Pacific will grow at rapid rate over the forecast time-frame due to increasing investment in research and development to develop new products. The market in Latin America will grow at a substantial rate during the estimate period. The Africa and Middle Eastern region is expected to exhibit definite progression in the anticipated time-frame.

The report also includes detailed profiles of key players such as PTC Therapeutics Inc., F. Hoffmann-La Roche Ltd., Santhera Pharmaceuticals, Wave Life Sciences Ltd., and Sarepta Therapeutics Inc. among others.

This report segments the Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market as follows:

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: By Type

  • Small Molecules
  • Biologics

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Related Reports

N95 Mask Market by Usage (Reusable and Disposable), and End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5348 | Report Format:

The report covers forecast and analysis for the N95 mask market on a global and regional level. The study provides historic data from 2016to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the N95 mask market along with the...Read More

Tissue Engineering Market by Application (Gynecology, Cell Banking & Cord blood, Dental, Urology, Integumentary & Skin, Cardiology, Neurology, Musculoskeletal, Orthopedics, & Spine, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5337 | Report Format:

The report covers forecast and analysis for the tissue engineering market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue engineering ma...Read More

Robotic Prosthetic Market by Extremity (Upper Body Prosthetics and Lower Body Prosthetics), and Technology (Myoelectric Prosthetics and MPC Prosthetics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5336 | Report Format:

The report covers forecast and analysis for the robotic prosthetic market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the robotic prosthetic ...Read More

Long-Term Care Market by Service (Hospice, Home Healthcare, Assisted Living Facilities, Nursing care, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5335 | Report Format:

The report covers forecast and analysis for the long-term care market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the long-term care market alo...Read More

Leprosy Treatment Market by Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), by Route of Administration (Oral, Injectable, Topical), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Mar-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5334 | Report Format:

The report covers forecast and analysis for the Leprosy Treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Leprosy Treatment ma...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.